Risk factors of chronic kidney disease in Cisplatin-based hyperthermia intrap...
收藏B2FIND2026-03-21 收录
官方服务：
资源简介：
Raw data Date Submitted: 2023-09-19
应用场景：
相关数据集
Differences between the oral changes presented by patients with solid and hematologic tumors during the chemotherapeutic treatment
Abstract Objective: This study sought to identify the differences between the oral changes presented by patients with solid and hematologic tumors during chemotherapeutic treatment. Methodology: Thi
NIAID Data Ecosystem50
Additional file 1 of The prevalence, risk factors, and prognostic value of venous thromboembolism in ovarian cancer patients receiving chemotherapy: a systematic review and meta-analysis
Additional file 1. The detailed search strategy.
NIAID Data Ecosystem20
Chemotherapy-induced thrombocytopenia Market
Report of Chemotherapy-induced thrombocytopenia is currently supplying a comprehensive analysis of many things which are liable for economy growth and factors which could play an important part in the
IMR REPORTS20
Supplementary Material for: Malaria as Potential Etiology and Treatment Complicating Factor in DLBCL Patient: a Case Report
Malaria is known to be a significant risk factor and also a potential complicating factor during the treatment of lymphoid malignancy. There has not been a reported case of malaria reactivation that o
Figshare2023-05-12 更新30
Use of colony-stimulating factor primary prophylaxis and incidence of febrile neutropenia from 2010-2016: a longitudinal assessment
Background: Guidelines recommend primary prophylactic use of colony-stimulating factor (PP-CSF) when risk of febrile neutropenia (FN)—based on chemotherapy and patient risk factors—is high. Whether an
Taylor & Francis Group2020-02-20 更新20
